FDA Inspection 1039096 — Agnes Linglart, M.D., Ph.D.
The FDA completed an inspection of Agnes Linglart, M.D., Ph.D. on Dec 22, 2017 in Le Kremlin Bicetre Cedex. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 22, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Le Kremlin Bicetre Cedex (France)
Additional Details
Clinical Investigator (CI)